Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
ARNA Arena Pharmaceuticals, Inc. daily Stock Chart
ARNA [NASD]
Arena Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E5.90 EPS (ttm)7.64 Insider Own0.10% Shs Outstand50.11M Perf Week1.23%
Market Cap2.26B Forward P/E- EPS next Y-8.51 Insider Trans-51.93% Shs Float49.22M Perf Month-8.35%
Income397.60M PEG- EPS next Q-2.37 Inst Own84.80% Short Float7.62% Perf Quarter-0.20%
Sales806.40M P/S2.80 EPS this Y-220.20% Inst Trans0.04% Short Ratio5.89 Perf Half Y-0.35%
Book/sh21.38 P/B2.11 EPS next Y7.90% ROA31.60% Target Price70.09 Perf Year-7.09%
Cash/sh14.76 P/C3.06 EPS next 5Y- ROE34.10% 52W Range32.95 - 64.48 Perf YTD-0.73%
Dividend- P/FCF4.01 EPS past 5Y36.80% ROI33.20% 52W High-30.07% Beta1.31
Dividend %- Quick Ratio16.90 Sales past 5Y85.20% Gross Margin- 52W Low36.84% ATR3.72
Employees320 Current Ratio16.90 Sales Q/Q-65.10% Oper. Margin59.90% RSI (14)54.29 Volatility7.51% 10.27%
OptionableYes Debt/Eq0.05 EPS Q/Q-226.80% Profit Margin49.30% Rel Volume1.05 Prev Close43.99
ShortableYes LT Debt/Eq0.04 EarningsFeb 26 AMC Payout0.00% Avg Volume636.92K Price45.09
Recom1.70 SMA209.72% SMA50-1.42% SMA200-9.88% Volume665,657 Change2.50%
Mar-31-20Initiated Guggenheim Buy $95
Mar-26-20Upgrade BofA/Merrill Neutral → Buy $47 → $56
Jan-31-20Upgrade JP Morgan Neutral → Overweight $58
Nov-13-19Initiated BofA/Merrill Neutral $51
Dec-13-18Initiated Berenberg Buy $55
May-31-18Initiated RBC Capital Mkts Outperform $65
Mar-21-18Upgrade Needham Hold → Buy $60
Mar-20-18Reiterated JMP Securities Mkt Outperform $63 → $79
Jan-18-18Resumed Credit Suisse Outperform $44
Jan-18-18Initiated Credit Suisse Outperform $44
Jan-03-18Upgrade Wells Fargo Market Perform → Outperform
Jul-11-17Reiterated Citigroup Buy $23 → $37
Jul-07-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Jun-27-17Initiated Citigroup Buy $23
May-19-17Initiated Leerink Partners Outperform $5
Sep-15-16Initiated FBR & Co. Outperform $6
Mar-01-16Reiterated RBC Capital Mkts Sector Perform $2 → $1.50
Nov-11-15Reiterated RBC Capital Mkts Sector Perform $5 → $2
Oct-28-15Reiterated WallachBeth Buy $6 → $4
May-12-15Reiterated WallachBeth Buy $8 → $6
Apr-01-20 04:01PM  Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR) PR Newswire
Mar-30-20 08:30AM  Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor PR Newswire -5.43%
Mar-18-20 04:01PM  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire -11.19%
02:29PM  Top Biotech Stocks for Q2 2020 Investopedia
Mar-09-20 01:30PM  6 Cheap Health Care Stocks GuruFocus.com -6.58%
10:18AM  Arena's Pipeline Holds Promise, Plunging Revenues a Concern Zacks
Feb-28-20 05:38AM  Arena Pharmaceuticals, Inc. Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For Next Year Simply Wall St.
Feb-27-20 01:48PM  Edited Transcript of ARNA earnings conference call or presentation 26-Feb-20 9:30pm GMT Thomson Reuters StreetEvents -5.75%
10:40AM  Arena Pharmaceuticals (ARNA) Q4 Earnings Miss, Revenues Top Zacks
Feb-26-20 04:01PM  Arena Announces Management and Program Updates and Reports Fourth Quarter and Full-Year 2019 Financial Results PR Newswire
09:36AM  The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates Benzinga
Feb-21-20 04:11PM  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
Feb-20-20 08:30AM  Arena Pharmaceuticals to Present at the Upcoming Investor Conferences PR Newswire
Feb-19-20 04:06PM  Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2019 Financial Results and Provide Corporate Update on February 26 PR Newswire
Feb-13-20 06:09AM  Our Take On Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) CEO Salary Simply Wall St.
Feb-11-20 03:06PM  Arena Pharmaceuticals' Presence at the European Crohn's and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community PR Newswire
Jan-31-20 03:45PM  Top Marijuana Stocks on the NASDAQ Investopedia
Jan-17-20 08:16AM  Arena's (ARNA) Heart Failure Candidate Gets Fast Track Status Zacks
Jan-16-20 09:00AM  FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients PR Newswire
Jan-13-20 04:01PM  Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary PR Newswire
Jan-08-20 09:27AM  2019 Review: Top Hedge Fund Stocks vs. Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey
08:30AM  Arena Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 16 PR Newswire
Jan-07-20 07:57AM  The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering Benzinga
Jan-06-20 04:01PM  Arena Pharmaceuticals Highlights Strategic Plan Driving Near and Long-term Growth with Eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New IND Per Year for the Next 5 Years PR Newswire
Jan-03-20 09:01AM  Arena (ARNA) Expands Strategic Deal With Beacon Discovery Zacks
Jan-02-20 08:30AM  Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets PR Newswire
Dec-30-19 08:52AM  Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A Volatile Stock? Simply Wall St.
Dec-19-19 02:32PM  6 Stocks With Low Price-Earnings Ratios GuruFocus.com
Dec-13-19 02:31PM  The MLB allows players to smoke marijuana Yahoo Finance Video
Dec-03-19 04:35PM  Hedge Funds Are Done Buying Arena Pharmaceuticals, Inc. (ARNA)? Insider Monkey
Nov-27-19 06:34PM  Edited Transcript of ARNA earnings conference call or presentation 7-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-26-19 08:30AM  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire
Nov-18-19 04:01PM  California Life Sciences Association Honors Arena Pharmaceuticals at the Pantheon 2019 DiNA Awards for the Deal of the Year PR Newswire
Nov-14-19 09:00AM  Everest Medicines Achieved First Patient Dosing Milestone in Etrasimod Phase 3 Clinical Study in Ulcerative Colitis Patients in Asia GlobeNewswire
Nov-10-19 07:43AM  Can You Imagine How Chuffed Arena Pharmaceuticals's (NASDAQ:ARNA) Shareholders Feel About Its 189% Share Price Gain? Simply Wall St.
Nov-08-19 08:56AM  Arena Pharmaceuticals' (ARNA) Q3 Loss Widens, Revenues Beat Zacks
Nov-07-19 04:01PM  Arena Reports Third Quarter Financial Results with Continued Progress on Clinical Programs PR Newswire
Nov-06-19 08:30AM  Arena Pharmaceuticals Presented New Data Highlighting the Human Mass Balance and Metabolism Profile of Etrasimod at AAPS PR Newswire
Nov-05-19 05:41PM  Arena Pharmaceuticals to Present at Upcoming Investor Conferences PR Newswire
Oct-31-19 11:45AM  United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up Zacks
08:30AM  Arena Pharmaceuticals to Release Third Quarter 2019 Financial Results and Provide Corporate Update on November 7 PR Newswire
Oct-28-19 08:30AM  Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis PR Newswire
Oct-23-19 01:26PM  Hedge Funds Have Never Been This Bullish On Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey
Oct-22-19 04:01PM  Arena Pharmaceuticals Presented New Data Analyses Demonstrating the Long-Term Safety and Efficacy of Once-Daily Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis at UEG Week PR Newswire
Oct-18-19 03:01AM  Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community PR Newswire
Oct-05-19 09:51AM  What Kind Of Shareholder Owns Most Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock? Simply Wall St.
Sep-26-19 08:30AM  Arena Pharmaceuticals Presented New Data from the Phase 2 OASIS trial for Etrasimod at the World Congress of Gastroenterology Meeting PR Newswire -6.14%
Sep-25-19 08:30AM  Arena Pharmaceuticals to Present at the Cantor Global Healthcare Conference on October 2 PR Newswire
Sep-17-19 08:30AM  Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual Meeting PR Newswire
Sep-12-19 11:25AM  United Therapeutics' Trevyent NDA for PAH Accepted by FDA Zacks
Sep-10-19 11:15PM  Arena Pharmaceuticals Inc (ARNA) EVP, General Counsel & Sec Steven W Spector Sold $2. ... GuruFocus.com
Sep-09-19 08:30AM  Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting PR Newswire
Sep-05-19 11:23AM  Does Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) CEO Salary Compare Well With Others? Simply Wall St.
Aug-28-19 08:30AM  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire
Aug-13-19 12:44PM  25 Biggest Marijuana Companies in the World Insider Monkey
Aug-08-19 04:47PM  Edited Transcript of ARNA earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents -7.77%
04:08PM  This Biotech Crashed On 'Erroneous' Report Plus 2 Stocks That Diverged Investor's Business Daily
10:34AM  Arena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues Meet Zacks
04:23AM  Arena Pharmaceuticals Inc (ARNA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 04:01PM  Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials PR Newswire
Aug-06-19 03:50PM  Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A High Quality Stock To Own? Simply Wall St.
Aug-01-19 09:49AM  United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y Zacks
Jul-31-19 08:30AM  Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7 PR Newswire
Jul-29-19 10:34AM  Analysts Estimate Arena Pharmaceuticals (ARNA) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-25-19 09:00AM  Arena Pharmaceuticals (ARNA) Upgraded to Buy: Here's Why Zacks
08:30AM  Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome PR Newswire
Jul-09-19 01:32PM  Should Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Be Your Next Stock Pick? Simply Wall St.
Jun-18-19 12:30PM  A Company's First Profit Can Mean Big Profits for Investors Zacks
10:38AM  Arena Initiates Dosing in Pivotal Colitis Study on Etrasimod Zacks
Jun-17-19 08:30AM  Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis PR Newswire
Jun-14-19 06:29PM  Did Hedge Funds Drop The Ball On Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey
Jun-13-19 06:29PM  Edited Transcript of ARNA earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
08:30AM  Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19 PR Newswire
Jun-07-19 09:30AM  Why Is Arena Pharmaceuticals (ARNA) Up 9.1% Since Last Earnings Report? Zacks
Jun-06-19 12:32PM  Does Market Volatility Impact Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) Share Price? Simply Wall St.
May-21-19 07:30AM  Corvidia Therapeutics Announces Dr. Preston Klassen Joins its Board of Directors PR Newswire
May-17-19 08:30AM  Arena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community PR Newswire
May-13-19 09:00AM  All You Need to Know About Arena Pharmaceuticals (ARNA) Rating Upgrade to Buy Zacks -6.14%
08:30AM  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire
May-10-19 07:45PM  Arena Pharmaceuticals Inc (ARNA) Q1 2019 Earnings Call Transcript Motley Fool
07:04AM  Did Business Growth Power Arena Pharmaceuticals's (NASDAQ:ARNA) Share Price Gain of 226%? Simply Wall St.
May-09-19 04:24PM  S&P 500, Nasdaq end lower for fourth day after Trump claims China broke the deal MarketWatch
09:03AM  Arena Pharmaceuticals' (ARNA) Loss Widens in Q1 But Stock Up Zacks
May-08-19 04:46PM  Arena Pharmaceutical shares slide after drug maker reports disappointing financial results MarketWatch
04:01PM  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2019 Financial Results PR Newswire
May-02-19 09:26AM  United Therapeutics (UTHR) Down Despite Q1 Earnings Beat Zacks
May-01-19 08:30AM  Arena Pharmaceuticals to Release First Quarter 2019 Financial Results and Provide Corporate Update on May 8 PR Newswire
Apr-30-19 02:50PM  Heres What Hedge Funds Think About Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey
Apr-24-19 11:30AM  The New Cannabis ETF Is Already Making Additions Benzinga
Apr-03-19 11:52AM  What Type Of Shareholder Owns Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA)? Simply Wall St.
08:30AM  Arena Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 10 PR Newswire
Mar-28-19 09:30AM  Why Is Arena Pharmaceuticals (ARNA) Down 10.1% Since Last Earnings Report? Zacks
Mar-26-19 07:30AM  New Research Coverage Highlights The Blackstone Group, Arena Pharmaceuticals, Arrow Electronics, AdvanSix, KBR, and RPM International Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Mar-18-19 03:36PM  These 3 Cannabis Stocks Are Set to Skyrocket, Say Analysts SmarterAnalyst
Mar-08-19 08:30AM  Arena Pharmaceuticals Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th Congress of European Crohn's and Colitis Organisation PR Newswire
Mar-01-19 06:55AM  Edited Transcript of ARNA earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 10:16AM  United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates Zacks
Feb-27-19 08:25AM  Arena Pharmaceuticals (ARNA) Beats on Q4 Earnings & Revenues Zacks
Feb-26-19 08:52PM  Arena Pharmaceuticals Inc (ARNA) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results PR Newswire
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include ralinepag (APD811), which is in Phase III trial to treat pulmonary arterial hypertension; etrasimod (APD334) for ulcerative colitis, and Crohn's disease, as well as for atopic dermatitis and other indications; and Olorinab (APD371), which is in Phase II trial for the treatment of gastrointestinal pain. It is also developing APD418, a calcium-independent myofilament derepressor for the treatment of decompensated heart failure. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Axovant Sciences GmbH; Outpost Medicine LLC; CY Biotech Company Limited; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPECTOR STEVEN WEVP, General Counsel & SecFeb 27Option Exercise14.907,970118,75317,437Feb 28 06:02 PM
Munshi AmitPresident and CEOFeb 13Option Exercise14.6015,200221,92022,950Feb 14 07:37 PM
Lind Kevin RobertExecutive VP and CFOFeb 13Option Exercise26.604,500119,7007,957Feb 14 07:40 PM
SPECTOR STEVEN WEVP, General Counsel & SecFeb 13Option Exercise35.647,436265,00120,303Feb 14 07:43 PM
Lind Kevin RobertExecutive VP and CFOFeb 13Sale55.004,500247,5003,457Feb 14 07:40 PM
Munshi AmitPresident and CEOFeb 13Sale55.0015,200836,0007,750Feb 14 07:37 PM
SPECTOR STEVEN WEVP, General Counsel & SecFeb 13Sale55.0010,836595,9809,467Feb 14 07:43 PM
Aurentz VincentExecutive VP and CBOFeb 05Sale50.009,000450,0000Feb 07 04:34 PM
Munshi AmitPresident and CEOFeb 05Sale50.007,129356,4507,750Feb 07 04:31 PM
Lisicki RobertEVP, Chief Commercial OfficerNov 13Sale45.834,429203,0000Nov 26 05:44 PM
WOODS RANDALL EDirectorNov 12Option Exercise32.503,04698,99517,276Nov 13 08:14 PM
WOODS RANDALL EDirectorNov 12Sale46.733,046142,34014,230Nov 13 08:14 PM
SPECTOR STEVEN WEVP, General Counsel & SecOct 14Option Exercise0.006,300015,990Oct 16 08:22 PM
Lisicki RobertEVP, Chief Commercial OfficerOct 14Option Exercise0.006,30006,300Oct 16 08:21 PM
Klassen PrestonEVP and CMOOct 14Option Exercise0.006,30006,300Oct 16 08:20 PM
Aurentz VincentExecutive VP and CBOOct 14Option Exercise0.009,00009,000Oct 16 08:19 PM
Lind Kevin RobertExecutive VP and CFOOct 14Option Exercise0.006,30006,548Oct 16 08:18 PM
Munshi AmitPresident and CEOOct 14Option Exercise0.0011,700019,450Oct 16 08:17 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 10Option Exercise15.5012,627195,71922,317Sep 10 09:03 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 10Sale50.2812,627634,8739,690Sep 10 09:03 PM
Aurentz VincentExecutive VP and CBOSep 09Option Exercise25.2565,0001,641,50065,000Sep 10 09:05 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 09Option Exercise18.7421,457402,18641,147Sep 10 09:03 PM
Aurentz VincentExecutive VP and CBOSep 09Sale50.7265,0003,296,7000Sep 10 09:05 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 09Sale50.7231,4571,595,5159,690Sep 10 09:03 PM
Soni Manmeet SinghDirectorJun 14Sale55.891,21768,0225,087Jun 17 06:53 PM
FETZER OLIVERDirectorJun 14Sale55.891,52585,2384,179Jun 17 06:41 PM
Dallas Jayson Donald AlexanderDirectorJun 14Sale55.901,52585,2404,179Jun 17 06:38 PM
open in yahoo | open in reuters | open in google